1.11.1.7	peroxidase	eosinophil	isolated from peritoneal lavage and gastric wall	684225	
1.11.2.2	myeloperoxidase	eosinophil	-	439734	
1.13.11.12	linoleate 13S-lipoxygenase	eosinophil	eosinophils are the major cell type expressing 12/15-LOX during the corneal wound healing process	764651	
1.13.11.31	arachidonate 12-lipoxygenase	eosinophil	-	742000, 765651	
1.13.11.31	arachidonate 12-lipoxygenase	eosinophil	eosinophils are the major cell type expressing 12/15-LOX during the corneal wound healing process	764651	
1.13.11.33	arachidonate 15-lipoxygenase	eosinophil	-	639237, 639243, 639247, 639248, 689807, 703628, 706579, 742000, 742613, 765651	
1.13.11.33	arachidonate 15-lipoxygenase	eosinophil	15-lipoxygenase activity is 100fold greater in eosinophils than in neutrophils	639246	
1.13.11.33	arachidonate 15-lipoxygenase	eosinophil	15-LOX-1	706877	
1.13.11.33	arachidonate 15-lipoxygenase	eosinophil	eosinophil 15-lipoxygenase is a leukotriene A4 synthase	639267	
1.13.11.33	arachidonate 15-lipoxygenase	eosinophil	eosinophils are the major cell type expressing 12/15-LOX during the corneal wound healing process	764651	
1.13.11.33	arachidonate 15-lipoxygenase	eosinophil	high expression	706579	
1.13.11.33	arachidonate 15-lipoxygenase	eosinophil	peak-I 15 lipoxygenase is the predominant enzyme form	639240	
1.13.11.34	arachidonate 5-lipoxygenase	eosinophil	-	704997, 711100, 742001	
1.14.14.94	leukotriene-B4 20-monooxygenase	eosinophil	-	685340	
1.6.3.1	NAD(P)H oxidase (H2O2-forming)	eosinophil	-	742310	
1.6.3.1	NAD(P)H oxidase (H2O2-forming)	eosinophil	inside-out patches from eosinophils activated with PMA	671829	
2.3.1.147	glycerophospholipid arachidonoyl-transferase (CoA-independent)	eosinophil	-	701639	
2.3.1.37	5-aminolevulinate synthase	eosinophil	high expression of isoform ALAS1	703855	
2.4.1.152	4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase	eosinophil	FT-IV mRNA is the predominant transcript in eosinophils isolated from human blood, TGF-beta1 upregulates FT-IV mRNA expression	671207	
2.4.1.152	4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase	eosinophil	FT-VII mRNA is weakly expressed in eosinophils isolated from human blood, its expression is up-regulated by TGF-beta1 to some extent	671207	
2.7.11.18	myosin-light-chain kinase	eosinophil	-	661920	
3.1.1.5	lysophospholipase	eosinophil	-	680335	
3.1.3.16	protein-serine/threonine phosphatase	eosinophil	-	692321	
3.3.2.6	leukotriene-A4 hydrolase	eosinophil	-	708181	
3.3.2.6	leukotriene-A4 hydrolase	eosinophil	roughly two-thirds of the eosinophil population express 5-lipoxygenase (5-LO), and of those 5-LO-expressing cells, over 99% express both LTA4 hydrolase and LTC4 synthase. Peripheral blood eosinophils cultured in vitro produce LTB4 when unstimulated, and they release significantly elevated levels of LTB4 when stimulated with aspirin-lysine, PMA, and platelet-activating factor	752450	
3.3.2.6	leukotriene-A4 hydrolase	eosinophil	used as control for the expression of 5-LO pathway enzymes	679295	
3.4.14.5	dipeptidyl-peptidase IV	eosinophil	-	699329	
3.5.3.15	protein-arginine deiminase	eosinophil	-	711811	
3.6.1.2	trimetaphosphatase	eosinophil	-	209941	
4.4.1.20	leukotriene-C4 synthase	eosinophil	-	644485, 644486, 644488	
4.4.1.20	leukotriene-C4 synthase	eosinophil	co-localization for 5-lipoxygenase activating protein, LTC4 synthase, cyclooxygenase-1 and prostaglandin D2 synthase in nasal biopsies, 10% of LTC4 synthase-positive cells being eosinophils in perennial and seasonal allergic rhinitis biopsies. In the rhinitic biopsies, LTC4 synthase is detectable in 19% of eosinophils	708181	
5.2.1.8	peptidylprolyl isomerase	eosinophil	primary	705854	
5.3.2.1	phenylpyruvate tautomerase	eosinophil	-	703331	
5.3.3.12	L-dopachrome isomerase	eosinophil	-	703331, 727347